<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Psychiatr Res</journal-id><journal-id journal-id-type="iso-abbrev">J Psychiatr Res</journal-id><journal-id journal-id-type="pmc-domain-id">2665</journal-id><journal-id journal-id-type="pmc-domain">vapa</journal-id><journal-title-group><journal-title>Journal of psychiatric research</journal-title></journal-title-group><issn pub-type="ppub">0022-3956</issn><issn pub-type="epub">1879-1379</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>VA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10149594</article-id><article-id pub-id-type="pmcid-ver">PMC10149594.1</article-id><article-id pub-id-type="pmcaid">10149594</article-id><article-id pub-id-type="pmcaiid">10149594</article-id><article-id pub-id-type="manuscript-id">NIHMS1890599</article-id><article-id pub-id-type="pmid">37019069</article-id><article-id pub-id-type="doi">10.1016/j.jpsychires.2023.03.037</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1890599</article-id><article-id pub-id-type="manuscript-id-alternative">VAPA1890599</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The efficacy and safety of buprenorphine for the treatment of depression: A systematic review and meta-analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Riblet</surname><given-names initials="NB">Natalie B.</given-names></name><degrees>MD MPH</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Young-Xu</surname><given-names initials="Y">Yinong</given-names></name><degrees>ScD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shiner</surname><given-names initials="B">Brian</given-names></name><degrees>MD MPH</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schnurr</surname><given-names initials="PP">Paula P.</given-names></name><degrees>PhD</degrees><xref rid="A4" ref-type="aff">4</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Watts</surname><given-names initials="BV">Bradley V.</given-names></name><degrees>MD MPH</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A3" ref-type="aff">3</xref><xref rid="A5" ref-type="aff">5</xref></contrib></contrib-group><aff id="A1"><label>1.</label>Veterans Affairs Medical Center, Mental Health Service, 215 North Main Street, White River Junction, VT 05009 USA</aff><aff id="A2"><label>2.</label>Geisel School of Medicine at Dartmouth, Department of Psychiatry and Dartmouth Institute, 1 Rope Ferry Road, Hanover NH, 03755, USA</aff><aff id="A3"><label>3.</label>Geisel School of Medicine at Dartmouth, Department of Psychiatry, 1 Rope Ferry Road, Hanover NH, 03755, USA</aff><aff id="A4"><label>4.</label>National Center for PTSD, 215 North Main Street, White River Junction, VT 05009, USA</aff><aff id="A5"><label>5.</label>Veterans Rural Health Resource Center, White River Junction VA Medical Center, White River Junction, VT, 05009, USA</aff><author-notes><corresp id="CR1"><bold>Contact Information for Corresponding Author</bold>: Natalie Riblet, MD MPH, Veterans Affairs Medical Center, Building 65, 215 North Main Street, White River Junction, VT, 05009. <email>Natalie.riblet@dartmouth.edu</email>; Phone 1-802-295-9363; Fax: None</corresp><fn fn-type="COI-statement" id="FN1"><p id="P55"><bold>Conflict of Interest Statement:</bold> The authors do not believe that they have any conflicts of interest directly pertinent to this current publication.</p></fn></author-notes><pub-date pub-type="ppub"><month>5</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>30</day><month>3</month><year>2023</year></pub-date><volume>161</volume><issue-id pub-id-type="pmc-issue-id">434666</issue-id><fpage>393</fpage><lpage>401</lpage><pub-history><event event-type="nihms-submitted"><date><day>23</day><month>04</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>05</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>05</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 11:25:31.053"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1890599.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P1">Depressive disorders are common. Many patients with major depression do not achieve remission with available treatments. Buprenorphine has been raised as a potential treatment for depression as well as suicidal behavior but may pose certain risks.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">A meta-analysis comparing the efficacy, tolerability, and safety of buprenorphine (or combinations such as buprenorphine/samidorphan) versus control in improving symptoms in patients with depression. Medline, Cochrane Database, PsycINFO, Excerpta Medica Database and The Cumulative Index to Nursing and Allied Health Literature were searched from inception through January 2, 2022. Depressive symptoms were pooled using Hedge&#8217;s g with 95% Confidence Intervals (CI). Tolerability, safety, suicide outcomes were summarized qualitatively.</p></sec><sec id="S3"><title>Results:</title><p id="P3">11 studies (N=1,699) met inclusion criteria. Buprenorphine had a small effect on depressive symptoms (Hedges&#8217; g 0.17, 95%CI: 0.05 &#8211; 0.29). Results were driven by six trials of buprenorphine/samidorphan (N=1,343, Hedges&#8217;s g 0.17, 95%CI: 0.04 &#8211; 0.29). One study reported significant improvement in suicidal thoughts (Least Squares Mean Change: &#8722;7.1, 95%CI: &#8722;12.0 &#8211; 2.3). Most studies found buprenorphine was well-tolerated with no evidence of abuse behavior or dependency.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P4">Buprenorphine may have a small benefit for depressive symptoms. Future research should clarify the dose response relationship between buprenorphine and depression.</p></sec></abstract><kwd-group><kwd>Buprenorphine</kwd><kwd>depression</kwd><kwd>suicide</kwd><kwd>safety</kwd><kwd>tolerability</kwd><kwd>meta-analysis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>